To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene UTP11LTABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
267 supporting clones for gene UTP11L back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
BF576356 muscle (skeletal) .a 1 to 573 1 to 573   tiling clone,   573/573
(100 %)
0 diff
(100 %id)
BU940926 mixed (pool of 40 RNAs) .a 87 to 811 1 to 730       729/771
(94 %)
26 diff
(96.7 %id)
NM_016037.3   .a 90 to 2138 1 to 2049 exact RefSeq, AAA   2049/2049
(100 %)
0 diff
(100 %id)
BU928373 brain, glioblastoma .a 93 to 744 1 to 657       657/833
(78 %)
15 diff
(98.2 %id)
DT219961 brain .a 94 to 665 1 to 572       572/572
(100 %)
6 diff
(99.0 %id)
CD695253 normal nasopharynx .a 96 to 484 47 to 435       389/435
(89 %)
6 diff
(98.7 %id)
DA369109 subthalamic nucleus .a 97 to 670 2 to 575   capped   574/574
(100 %)
1 diff
(99.9 %id)
DA746726   .a 97 to 656 2 to 561   capped   560/560
(100 %)
2 diff
(99.7 %id)
DA750722   .a 97 to 664 2 to 569   capped   568/568
(100 %)
1 diff
(99.9 %id)
DA813926   .a 97 to 661 2 to 566   capped   565/565
(100 %)
1 diff
(99.9 %id)
DB178020 kidney, tumor tissue .a 97 to 652 2 to 557   capped   556/556
(100 %)
0 diff
(100 %id)
BG483995 lung .a 98 to 748 1 to 648       648/795
(81 %)
17 diff
(97.9 %id)
BF242999 bone marrow, from acute myelogenous leukemia .a 99 to 702 1 to 605       609/859
(70 %)
15 diff
(98.3 %id)
FN124147 breast carcinoma .a 100 to 171 1 to 74       74/74
(100 %)
6 diff
(91.9 %id)
BX951341   .a 101 to 787 1 to 687       687/687
(100 %)
1 diff
(99.9 %id)
BF672201 muscle (skeletal) .a 101 to 736 1 to 629       629/629
(100 %)
10 diff
(98.5 %id)
CD702156 normal nasopharynx .a 102 to 563 20 to 480       461/480
(96 %)
6 diff
(98.8 %id)
AL711704 human skeletal muscle .a 102 to 672 11 to 582       572/582
(98 %)
11 diff
(98.2 %id)
BU165746 testis .a 102 to 900 1 to 799       799/800
(99 %)
8 diff
(99.0 %id)
BI668918 brain, hypothalamus .a 103 to 1021 7 to 925 K34R F213S V234G K235E K236E ...     919/925
(99 %)
20 diff
(97.9 %id)
TI_44345625   .a 103 to 1021 85 to 1003 K34R F213S V234G K235E K236E ...     919/1003
(91 %)
20 diff
(98.1 %id)
DB106394 thymus .a 103 to 651 2 to 550   capped   549/549
(100 %)
0 diff
(100 %id)
BF676403 Prostate .a 104 to 596 1 to 495       495/495
(100 %)
5 diff
(99.0 %id)
BF790924 muscle (skeletal) .a 104 to 812 1 to 716       716/898
(79 %)
32 diff
(96.5 %id)
BU860995 mixed (pool of 40 RNAs) .a 104 to 701 1 to 601       601/610
(98 %)
8 diff
(98.7 %id)
BG566216 Liver .a 105 to 719 1 to 622       622/799
(77 %)
15 diff
(98.2 %id)
BG722644 testis .a 107 to 757 1 to 651       651/651
(100 %)
6 diff
(99.1 %id)
BF795982 lymph, lymphoma, cell line .a 108 to 714 1 to 608       606/949
(63 %)
5 diff
(99.5 %id)
BM452451 eye, retinoblastoma .a 109 to 724 13 to 630       618/1129
(54 %)
27 diff
(97.7 %id)
BU596603 mixed (pool of 40 RNAs) .a 109 to 856 1 to 754       754/786
(95 %)
16 diff
(98.0 %id)
BU858545 mixed (pool of 40 RNAs) .a 109 to 913 1 to 807       807/807
(100 %)
14 diff
(98.3 %id)
BU943261 mixed (pool of 40 RNAs) .a 109 to 859 1 to 751       751/753
(99 %)
14 diff
(98.2 %id)
BF575194 muscle (skeletal) .a 110 to 748 1 to 628       628/645
(97 %)
16 diff
(97.6 %id)
BF540938 hypernephroma, Kidney .a 111 to 738 1 to 610       610/872
(69 %)
20 diff
(97.8 %id)
BF576321 muscle (skeletal) .a 111 to 817 1 to 696       696/875
(79 %)
15 diff
(98.3 %id)
AF151852   .a 112 to 1136 1 to 1025 Q21E tiling clone,   1025/1025
(100 %)
6 diff
(99.5 %id)
CD693458 normal nasopharynx .a 112 to 454 17 to 364       348/364
(95 %)
12 diff
(96.8 %id)
CD694361 normal nasopharynx .a 112 to 750 23 to 661       639/661
(96 %)
8 diff
(98.8 %id)
CD697431 normal nasopharynx .a 112 to 508 23 to 419       397/419
(94 %)
6 diff
(98.6 %id)
AV715048   .a 112 to 709 1 to 603       603/605
(99 %)
20 diff
(96.7 %id)
DW430527 Liver .a 112 to 305 18 to 211       194/272
(71 %)
6 diff
(97.8 %id)
BM009623 amelanotic melanoma, cell line, skin .a 112 to 891 1 to 779       779/779
(100 %)
8 diff
(99.0 %id)
BM905928 leiomyosarcoma, uterus .a 112 to 474 1 to 374       374/972
(38 %)
14 diff
(98.6 %id)
BM474886 duodenal adenocarcinoma, cell line, small intestine .a 112 to 1061 1 to 957 T221H R222A D224I M226W D227I ...     957/1005
(95 %)
10 diff
(99.1 %id)
BQ082679 stomach .a 112 to 520 1 to 409       409/409
(100 %)
0 diff
(100 %id)
AA362915 ovary .a 113 to 336 1 to 226       226/228
(99 %)
9 diff
(96.1 %id)
AL711199 human skeletal muscle .a 113 to 607 1 to 495       495/495
(100 %)
1 diff
(99.8 %id)
TI_59384385   .a 113 to 891 65 to 842       778/778
(100 %)
7 diff
(99.2 %id)
BX422999 adult brain, brain .a 114 to 1240 1 to 1120 Q21S P22L G23A R25E K26N ...     1120/1131
(99 %)
14 diff
(98.8 %id)
AL599581   .a 114 to 728 1 to 615       615/615
(100 %)
6 diff
(99.1 %id)
BF977101 melanotic melanoma, high MDR, skin .a 114 to 779 1 to 659       659/822
(80 %)
25 diff
(97.0 %id)
BM807697 amelanotic melanoma, cell line, skin .a 114 to 919 1 to 809       809/1095
(73 %)
9 diff
(99.2 %id)
AL711104 human skeletal muscle .a 115 to 734 1 to 620       620/620
(100 %)
1 diff
(99.9 %id)
TI_154189743   .a 118 to 1021 51 to 940 K218E Q220X T221H R222A K223X ...     890/1019
(87 %)
22 diff
(97.9 %id)
BF028087 bladder, carcinoma, cell line .a 120 to 747 5 to 638       634/922
(68 %)
43 diff
(95.4 %id)
DN993122 brain, whole brain .a 121 to 807 21 to 705       685/705
(97 %)
5 diff
(99.3 %id)
BF674033 Prostate .a 123 to 753 1 to 637       637/821
(77 %)
19 diff
(97.7 %id)
BF670642 muscle (skeletal) .a 123 to 725 1 to 601       601/789
(76 %)
8 diff
(99.0 %id)
BG532704 embryonal carcinoma, testis .a 123 to 564 1 to 442       442/442
(100 %)
1 diff
(99.8 %id)
BG674601 skin .a 124 to 608 1 to 493       493/931
(52 %)
17 diff
(98.2 %id)
BF572049 melanotic melanoma, high MDR, skin .a 125 to 618 1 to 499       499/524
(95 %)
15 diff
(97.2 %id)
AF067802   .a 126 to 1135 1 to 1009 E15N H16T R17E E18S R19E ...     1009/1009
(100 %)
4 diff
(99.7 %id)
BF977444 melanotic melanoma, high MDR, skin .a 126 to 860 1 to 738       738/839
(87 %)
21 diff
(97.5 %id)
BF978277 melanotic melanoma, high MDR, skin .a 126 to 843 1 to 711       709/880
(80 %)
22 diff
(97.5 %id)
BG499209 adenocarcinoma, Prostate .a 126 to 904 1 to 783       783/783
(100 %)
20 diff
(97.5 %id)
AA314256 colon .a 127 to 604 1 to 478       478/478
(100 %)
3 diff
(99.4 %id)
BU963214 mixed (pool of 40 RNAs) .a 128 to 305 1 to 178       178/222
(80 %)
1 diff
(99.6 %id)
AA317206 retina .a 131 to 492 1 to 367       367/367
(100 %)
6 diff
(98.4 %id)
CF126705 Chondrosarcoma Lung Metastasis cell lines, lung .a 132 to 828 1 to 697       697/697
(100 %)
3 diff
(99.6 %id)
DT217765 brain .a 133 to 803 1 to 668       668/668
(100 %)
3 diff
(99.6 %id)
BQ214899 melanotic melanoma, skin .a 136 to 862 12 to 742       731/862
(84 %)
17 diff
(98.1 %id)
BQ440706 leiomyosarcoma, uterus .a 136 to 1009 12 to 889 R253T     878/889
(98 %)
11 diff
(98.8 %id)
AA327697   .a 137 to 357 1 to 221       221/221
(100 %)
3 diff
(98.7 %id)
BX108295 germinal center B cell .a 137 to 865 1 to 730       730/730
(100 %)
3 diff
(99.6 %id)
AV659749 corresponding non cancerous liver tissue .a 137 to 536 1 to 401     Submitted on the opposite strand 401/401
(100 %)
3 diff
(99.3 %id)
T95453 liver and spleen .a 137 to 512 1 to 384       384/388
(98 %)
20 diff
(94.9 %id)
AA279602 germinal center B cell .a 137 to 365 1 to 227       227/233
(97 %)
9 diff
(96.2 %id)
CB265747 adipose .a 138 to 747 1 to 606       606/606
(100 %)
3 diff
(99.6 %id)
BU199162   .a 141 to 812 1 to 672       672/867
(77 %)
27 diff
(96.9 %id)
BQ654221 hepatocellular carcinoma, cell line, Liver .a 141 to 668 1 to 533       533/1310
(40 %)
14 diff
(99.0 %id)
AW953600   .a 143 to 518 2 to 377       376/529
(71 %)
8 diff
(98.5 %id)
CN363127 embryonic stem cells, cell lines H1, H7, andH9 .a 143 to 790 1 to 647       647/647
(100 %)
2 diff
(99.7 %id)
BF575912 muscle (skeletal) .a 143 to 753 1 to 609       609/635
(95 %)
20 diff
(96.9 %id)
BF671527 muscle (skeletal) .a 143 to 707 1 to 565       565/845
(66 %)
9 diff
(99.0 %id)
BY994274   .a 144 to 844 33 to 733       701/733
(95 %)
6 diff
(99.2 %id)
BC005182 Bladder, carcinoma .a 145 to 1115 1 to 971 exact available from MGC, AAA   971/971
(100 %)
3 diff
(99.7 %id)
TI_154110552   .a 145 to 1115 1031 to 69 A2R A4X F5S R6X K7R ... AAA   965/1004
(96 %)
20 diff
(98.1 %id)
AW380448 head_neck .a 147 to 747 1 to 599       598/599
(99 %)
16 diff
(97.4 %id)
CN363130 embryonic stem cells, DMSO-treated H9 cellline .a 147 to 826 1 to 680       680/680
(100 %)
0 diff
(100 %id)
D61557   .a 147 to 402 1 to 258       258/258
(100 %)
9 diff
(96.6 %id)
BE886574 leiomyosarcoma, uterus .a 148 to 914 1 to 761       761/764
(99 %)
15 diff
(98.1 %id)
BE150572 head_neck .a 153 to 821 5 to 670       666/671
(99 %)
21 diff
(96.9 %id)
BQ348532 head_neck .a 154 to 752 1 to 601       549/661
(83 %)
27 diff
(96.0 %id)
DA419836 cord Blood .a 155 to 719 2 to 566   capped   565/565
(100 %)
1 diff
(99.9 %id)
CN363129 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 155 to 665 1 to 512       512/512
(100 %)
1 diff
(99.9 %id)
DA823014 pericardium .a 155 to 709 2 to 556   capped   555/555
(100 %)
0 diff
(100 %id)
BF691574 melanotic melanoma, high MDR, skin .a 156 to 855 1 to 692       692/859
(80 %)
17 diff
(98.1 %id)
BG531111 embryonal carcinoma, testis .a 159 to 859 1 to 699       699/702
(99 %)
10 diff
(98.6 %id)
AK291900 skeletal muscle .a 160 to 1053 1 to 894 exact     894/894
(100 %)
0 diff
(100 %id)
CD699189 normal nasopharynx .a 160 to 807 28 to 675       648/675
(96 %)
7 diff
(99.0 %id)
DA512080 brain .a 161 to 689 2 to 530   capped   529/529
(100 %)
0 diff
(100 %id)
DA899744 skeletal muscle .a 161 to 698 2 to 539   capped   538/538
(100 %)
0 diff
(100 %id)
DB272488 uterus .a 161 to 712 2 to 553   capped   552/552
(100 %)
0 diff
(100 %id)
BE617144 adenocarcinoma, colon .a 162 to 712 1 to 551       551/551
(100 %)
0 diff
(100 %id)
AW380621 head_neck .a 163 to 810 14 to 655       642/655
(98 %)
10 diff
(98.5 %id)
BF028434 bladder, carcinoma, cell line .a 163 to 840 1 to 678       678/997
(68 %)
30 diff
(97.0 %id)
AA283599 germinal center B cell .a 166 to 616 1 to 447     Submitted on the opposite strand 449/447
(100 %)
6 diff
(98.7 %id)
AV713830   .a 169 to 859 1 to 689       689/706
(97 %)
5 diff
(99.3 %id)
TI_1948101684   .a 180 to 844 133 to 806       674/1179
(57 %)
16 diff
(98.7 %id)
CV027352 mixed .a 181 to 815 1 to 635       635/639
(99 %)
3 diff
(99.6 %id)
TI_1948102014   .a 181 to 647 117 to 584   fully sequenced,   468/584
(80 %)
6 diff
(99.0 %id)
AW380615 head_neck .a 185 to 762 1 to 578       578/578
(100 %)
11 diff
(98.1 %id)
R36819   .a 190 to 337 1 to 148       148/148
(100 %)
1 diff
(99.4 %id)
AA441867   .a 192 to 430 1 to 238       238/238
(100 %)
5 diff
(97.9 %id)
BQ348051 head_neck .a 211 to 721 1 to 515       515/515
(100 %)
18 diff
(96.6 %id)
AA143375   .a 214 to 377 1 to 165       167/166
(100 %)
11 diff
(93.4 %id)
CD677620 eye, Trabecular meshwork .a 224 to 805 1 to 582       582/582
(100 %)
0 diff
(100 %id)
AW380625 head_neck .a 242 to 859 634 to 18       618/634
(97 %)
14 diff
(97.8 %id)
BE150496 head_neck .a 242 to 859 625 to 10     Submitted on the opposite strand 617/632
(97 %)
5 diff
(99.3 %id)
TI_154122734   .a 242 to 1115 941 to 85   AAA   859/993
(86 %)
23 diff
(97.7 %id)
FN155852 breast carcinoma .a 267 to 383 115 to 1     Submitted on the opposite strand 115/115
(100 %)
4 diff
(96.6 %id)
CN363128 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 279 to 971 1 to 693       693/693
(100 %)
0 diff
(100 %id)
BI855706 breast, mammary adenocarcinoma, cell line .a 291 to 1021 1 to 730       730/730
(100 %)
1 diff
(99.9 %id)
TI_57186345   .a 291 to 1021 54 to 783       730/730
(100 %)
1 diff
(99.9 %id)
TI_149313089   .a 298 to 1115 896 to 90   AAA   809/951
(85 %)
22 diff
(97.7 %id)
BE893018 melanotic melanoma, skin .a 303 to 1047 1 to 743       743/968
(76 %)
15 diff
(98.5 %id)
TI_149313057   .a 304 to 1115 896 to 96   AAA   801/944
(84 %)
12 diff
(98.8 %id)
TI_1948101848   .a 306 to 941 788 to 145       644/1246
(51 %)
24 diff
(98.1 %id)
TI_154122744   .a 310 to 1115 884 to 88   AAA   797/975
(81 %)
11 diff
(98.9 %id)
CB141002 Liver .a 313 to 868 1 to 556       556/556
(100 %)
0 diff
(100 %id)
BQ224965 epithelioid carcinoma, Pancreas .a 316 to 1122 823 to 13   AAA Submitted on the opposite strand 811/840
(96 %)
5 diff
(99.5 %id)
TI_154110542   .a 318 to 1115 871 to 80   AAA   792/969
(81 %)
10 diff
(99.0 %id)
AA092914   .a 320 to 509 1 to 192       192/196
(97 %)
5 diff
(97.5 %id)
AJ713598 bone marrow .a 327 to 764 1 to 437       437/437
(100 %)
1 diff
(99.8 %id)
AA056934 uterus .a 327 to 568 1 to 244       244/244
(100 %)
2 diff
(99.2 %id)
BM824328 Ascites, stomach .a 337 to 995 3 to 661       659/661
(99 %)
6 diff
(99.1 %id)
TI_154102527   .a 340 to 1122 862 to 89   AAA   774/777
(99 %)
16 diff
(98.0 %id)
BM459226 lymph, lymphoma, cell line .a 345 to 1113 1 to 766       766/991
(77 %)
21 diff
(97.9 %id)
BQ689537 ductal carcinoma, cell line, Pancreas .a 349 to 1114 804 to 29   AAA Submitted on the opposite strand 776/914
(84 %)
18 diff
(98.1 %id)
TI_159695182   .a 352 to 1105 52 to 808     Submitted on the opposite strand 757/1081
(70 %)
17 diff
(98.5 %id)
BM710918 eye, fetal eyes .a 374 to 778 1 to 405   fully sequenced,   405/405
(100 %)
0 diff
(100 %id)
AA282707 germinal center B cell .a 387 to 704 319 to 2     Submitted on the opposite strand 318/319
(99 %)
0 diff
(100 %id)
TI_149313056   .a 391 to 1115 808 to 84   AAA   725/951
(76 %)
3 diff
(99.7 %id)
CA422550 cell lines, Chondrosarcoma .a 398 to 1115 735 to 19   AAA   717/723
(99 %)
7 diff
(99.1 %id)
TI_1948101513   .a 407 to 941 680 to 144       537/1344
(39 %)
24 diff
(98.3 %id)
TI_149307914   .a 407 to 1115 791 to 85   AAA   707/927
(76 %)
4 diff
(99.6 %id)
TI_154105225   .a 411 to 1115 785 to 85   AAA   701/702
(99 %)
8 diff
(98.9 %id)
TI_154103748   .a 419 to 1115 772 to 86   AAA   687/793
(86 %)
38 diff
(95.3 %id)
BQ000735 lung, Metastatic Chondrosarcoma .a 433 to 1115 701 to 19   AAA   683/683
(100 %)
0 diff
(100 %id)
CF541114 lung .a 433 to 1115 701 to 19   AAA   683/683
(100 %)
0 diff
(100 %id)
CN479979 Chondrosarcoma, Left Pubic Bone .a 433 to 1115 700 to 19   AAA   682/682
(100 %)
1 diff
(99.9 %id)
CF541143 lung .a 434 to 1115 700 to 19   AAA   682/682
(100 %)
0 diff
(100 %id)
CA446500 Chondrosarcoma, Left Pubic Bone .a 434 to 1115 699 to 19   AAA   681/681
(100 %)
3 diff
(99.6 %id)
TI_149276796   .a 438 to 1120 767 to 86   AAA   682/718
(94 %)
11 diff
(98.5 %id)
CF541113 lung .a 442 to 1115 692 to 19   AAA   674/674
(100 %)
0 diff
(100 %id)
CN479988 Chondrosarcoma, Left Pubic Bone .a 444 to 1115 690 to 19   AAA   672/673
(99 %)
0 diff
(100 %id)
BF111292 pooled .a 448 to 1115 674 to 11   AAA   664/664
(100 %)
11 diff
(98.4 %id)
CA423900 cell lines, Chondrosarcoma .a 448 to 1133 704 to 19   AAA   686/686
(100 %)
0 diff
(100 %id)
AI589633 anaplastic oligodendroglioma, brain .a 450 to 1117 676 to 8       669/677
(98 %)
7 diff
(99.0 %id)
BU686819 lung, Primary Lung Epithelial Cells .a 450 to 1115 685 to 19   AAA   667/667
(100 %)
1 diff
(99.9 %id)
BU625676 cell lines, Enchondroma .a 453 to 1115 681 to 19   AAA   663/663
(100 %)
0 diff
(100 %id)
BG029002 Bone, osteosarcoma, cell line .a 487 to 1115 1 to 630   AAA   630/630
(100 %)
5 diff
(99.3 %id)
CN479474 Chondrosarcoma, Left Pubic Bone .a 512 to 1122 629 to 19   AAA   611/611
(100 %)
0 diff
(100 %id)
BG474011 eye, retinoblastoma .a 516 to 1126 1 to 616       616/646
(95 %)
19 diff
(97.1 %id)
AW027187 thymus, pooled .a 519 to 1115 597 to 1       597/603
(99 %)
3 diff
(99.6 %id)
AI192946 lung .a 521 to 1117 597 to 2       596/604
(98 %)
4 diff
(99.4 %id)
TI_149307573   .a 521 to 1122 695 to 95   AAA   601/956
(62 %)
7 diff
(99.3 %id)
BF439523 pooled .a 526 to 937 412 to 1       412/448
(91 %)
12 diff
(97.4 %id)
BM979331 lung, Primary Lung Epithelial Cells .a 551 to 1122 590 to 19   AAA   572/572
(100 %)
3 diff
(99.5 %id)
EC473012 Prostate .a 553 to 656 1 to 102       102/107
(95 %)
4 diff
(96.3 %id)
BF062696 colon, colon tumor, RER+ .a 562 to 1115 554 to 1       554/554
(100 %)
2 diff
(99.7 %id)
BG035209 adenocarcinoma, cell line, Liver .a 574 to 1323 1 to 765       745/776
(96 %)
38 diff
(95.2 %id)
AA564222 germ cell tumor .a 580 to 1115 536 to 1       536/536
(100 %)
4 diff
(99.3 %id)
AA604235 adrenal adenoma, adrenal gland .a 580 to 1101 522 to 1       522/522
(100 %)
0 diff
(100 %id)
AI435094 pooled .a 580 to 1117 543 to 5       539/543
(99 %)
0 diff
(100 %id)
AI453732 adenocarcinoma, Pancreas .a 580 to 1115 536 to 1       536/536
(100 %)
0 diff
(100 %id)
TI_1948102015   .a 586 to 941 508 to 151   fully sequenced,   358/508
(70 %)
3 diff
(99.5 %id)
D62764   .a 591 to 839 1 to 249       249/249
(100 %)
2 diff
(99.2 %id)
BU677428 lung, Primary Lung Epithelial Cells .a 604 to 1120 535 to 19   AAA   517/517
(100 %)
3 diff
(99.5 %id)
FN170926 breast carcinoma .a 609 to 713 105 to 2     Submitted on the opposite strand 104/108
(96 %)
0 diff
(100 %id)
BU564509 mixed (pool of 40 RNAs) .a 611 to 859 1 to 249   AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 249/284
(87 %)
5 diff
(98.3 %id)
AI033674 parathyroid gland, parathyroid tumor .a 613 to 1117 509 to 5       505/509
(99 %)
0 diff
(100 %id)
AA622593 lung, lung tumor .a 615 to 1117 504 to 2       503/506
(99 %)
2 diff
(99.7 %id)
AI090679 heart .a 615 to 1115 511 to 11   AAA   501/524
(95 %)
2 diff
(99.7 %id)
AA865759 germinal center B cell .a 625 to 1136 518 to 7       512/518
(98 %)
0 diff
(100 %id)
AI740684 pooled .a 625 to 1111 506 to 20   AAA   487/487
(100 %)
5 diff
(99.0 %id)
AI582838 anaplastic oligodendroglioma, brain .a 633 to 1117 488 to 5       484/488
(99 %)
1 diff
(99.8 %id)
DN917525   .a 646 to 1115 470 to 1       470/470
(100 %)
2 diff
(99.6 %id)
AI497924 anaplastic oligodendroglioma, brain .a 646 to 1122 477 to 1       477/477
(100 %)
2 diff
(99.6 %id)
AA441805   .a 661 to 1117 459 to 3       457/459
(99 %)
0 diff
(100 %id)
AA714705 germinal center B-cells, tonsil .a 661 to 1069 457 to 49   AAA   409/409
(100 %)
1 diff
(99.8 %id)
AI219466 pooled .a 661 to 853 193 to 1       193/193
(100 %)
8 diff
(95.9 %id)
AI678266 Kidney .a 661 to 1115 480 to 26   AAA   455/455
(100 %)
6 diff
(98.7 %id)
BF577218 muscle (skeletal) .a 666 to 1115 1 to 451   AAA   451/451
(100 %)
9 diff
(98.1 %id)
CD654277 Embryonic Stem cells .a 671 to 1462 1 to 787       787/815
(96 %)
7 diff
(99.2 %id)
AI760761 2 pooled tumors (clear cell type), Kidney .a 677 to 1117 446 to 5       442/446
(99 %)
0 diff
(100 %id)
AA040453 uterus .a 683 to 1115 437 to 1       437/439
(99 %)
4 diff
(99.1 %id)
AI093005 heart .a 684 to 1122 443 to 5       439/443
(99 %)
0 diff
(100 %id)
AI016871 pooled .a 701 to 1115 438 to 26   AAA   413/413
(100 %)
4 diff
(99.1 %id)
CB047929 Prostate .a 701 to 1117 10 to 426   fully sequenced, AAA   417/426
(97 %)
8 diff
(98.2 %id)
CA311679 Human Lung Epithelial cells, lung .a 702 to 1115 432 to 19   AAA   414/415
(99 %)
3 diff
(99.3 %id)
CA445957 Chondrosarcoma, Left Pelvis .a 702 to 1115 432 to 19   AAA   414/414
(100 %)
1 diff
(99.8 %id)
AA700575 liver and spleen .a 710 to 1122 428 to 16   AAA   413/413
(100 %)
0 diff
(100 %id)
AW804199 uterus .a 715 to 1053 365 to 27       339/367
(92 %)
3 diff
(99.2 %id)
BM666013 eye, fetal eyes .a 717 to 1115 417 to 19   fully sequenced, AAA   399/399
(100 %)
0 diff
(100 %id)
BF062774 colon, colon tumor, RER+ .a 718 to 937 220 to 1       220/220
(100 %)
4 diff
(98.2 %id)
CX163866 human embryonic stem cells differentiated toan early endodermal cell type .a 724 to 1590 1 to 867   tiling clone,   867/867
(100 %)
2 diff
(99.8 %id)
AI539809 serous papillary carcinoma, high grade, 2pooled tumors, uterus .a 740 to 1117 385 to 8       378/385
(98 %)
0 diff
(100 %id)
BE698585 uterus_tumor .a 747 to 1103 16 to 375       358/378
(94 %)
20 diff
(94.8 %id)
AI240969 Kidney .a 748 to 1115 368 to 1       368/368
(100 %)
0 diff
(100 %id)
AI219468 pooled .a 750 to 1122 374 to 2       373/374
(99 %)
0 diff
(100 %id)
FN124838 breast carcinoma .a 760 to 859 104 to 4     Submitted on the opposite strand 101/104
(97 %)
0 diff
(100 %id)
FN100212 breast carcinoma .a 761 to 841 81 to 1     Submitted on the opposite strand 81/101
(80 %)
8 diff
(92.1 %id)
AI453735 adenocarcinoma, Pancreas .a 761 to 1115 355 to 1       355/355
(100 %)
2 diff
(99.5 %id)
BE933807 head_neck .a 767 to 960 202 to 10       193/202
(95 %)
0 diff
(100 %id)
T47705 fetal spleen, Spleen .a 767 to 1101 343 to 1       343/345
(99 %)
9 diff
(97.4 %id)
T89284 liver and spleen .a 768 to 1101 334 to 1       334/345
(96 %)
1 diff
(99.8 %id)
AA991787   .a 774 to 1117 346 to 3       344/346
(99 %)
0 diff
(100 %id)
AI123012 pooled .a 775 to 1117 349 to 7       343/349
(98 %)
0 diff
(100 %id)
CB047928 Prostate .a 788 to 1115 359 to 32   fully sequenced, AAA   328/328
(100 %)
0 diff
(100 %id)
AA860466 parathyroid gland, parathyroid tumor .a 791 to 1117 331 to 5       327/331
(98 %)
0 diff
(100 %id)
N35449 melanocyte .a 807 to 1084 1 to 281       281/281
(100 %)
3 diff
(99.0 %id)
AA748149 germinal center B cell .a 812 to 1115 343 to 40   AAA   304/304
(100 %)
1 diff
(99.7 %id)
D19697   .a 850 to 1117 1 to 268     Submitted on the opposite strand 268/269
(99 %)
1 diff
(99.7 %id)
BG227985   .a 853 to 1115 6 to 268   AAA   263/268
(98 %)
10 diff
(96.3 %id)
BG460340   .a 853 to 1115 6 to 268   AAA   263/268
(98 %)
10 diff
(96.3 %id)
FN116812 breast carcinoma .a 858 to 970 112 to 1     Submitted on the opposite strand 112/114
(98 %)
4 diff
(96.5 %id)
FN162160 breast carcinoma .a 883 to 1001 1 to 123       123/123
(100 %)
4 diff
(96.8 %id)
AI475673 B-cell, chronic lymphotic leukemia .a 894 to 1117 225 to 2       224/225
(99 %)
0 diff
(100 %id)
AA279763 germinal center B cell .a 899 to 1115 217 to 1       217/217
(100 %)
0 diff
(100 %id)
CA432743 mixed .a 926 to 1115 208 to 19   AAA   190/190
(100 %)
0 diff
(100 %id)
AA045539 uterus .a 928 to 1115 188 to 1       188/188
(100 %)
0 diff
(100 %id)
D29220   .a 931 to 1122 68 to 260       193/260
(74 %)
6 diff
(97.7 %id)
FN148386 breast carcinoma .a 932 to 1052 1 to 123       123/123
(100 %)
2 diff
(98.4 %id)
T95352 liver and spleen .a 947 to 1101 155 to 1       155/155
(100 %)
0 diff
(100 %id)
AA909357 pooled .a 950 to 1122 176 to 4       173/176
(98 %)
0 diff
(100 %id)
AW518806 adenocarcinoma, Pancreas .a 959 to 1122 166 to 3       164/166
(98 %)
0 diff
(100 %id)
AA143326   .a 965 to 1122 165 to 8       158/165
(95 %)
0 diff
(100 %id)
EC455549 Prostate .a 1001 to 1104 112 to 10       103/112
(91 %)
0 diff
(100 %id)
GD143425   .a 1027 to 1115 1 to 89   AAA   89/89
(100 %)
3 diff
(96.7 %id)
BF736390 bladder_tumor .a 1269 to 1644 35 to 413       379/413
(91 %)
20 diff
(95.2 %id)
BI062080 uterus_tumor .a 1397 to 1636 241 to 1       241/241
(100 %)
4 diff
(98.4 %id)
TI_154008766   .a 1459 to 2131 70 to 743   tiling clone, Submitted on the opposite strand 674/1056
(63 %)
4 diff
(99.7 %id)
BU620078 Cell Line, Chondrosarcoma .a 1484 to 2138 674 to 19   tiling clone, AAA   656/656
(100 %)
2 diff
(99.7 %id)
CV338306 amnion_normal .a 1527 to 1680 183 to 22     Submitted on the opposite strand 162/183
(88 %)
0 diff
(100 %id)
BI493106 cochlea, ear .a 1709 to 2134 437 to 12   tiling clone, Submitted on the opposite strand 426/437
(97 %)
0 diff
(100 %id)
BI493212 cochlea, ear .a 1709 to 2134 436 to 11     Submitted on the opposite strand 426/436
(97 %)
0 diff
(100 %id)
BI493105 cochlea, ear .a 1724 to 2134 1 to 411     Submitted on the opposite strand 411/421
(97 %)
0 diff
(100 %id)
BI493211 cochlea, ear .a 1725 to 2134 1 to 410     Submitted on the opposite strand 410/420
(97 %)
0 diff
(100 %id)
BM546032 ovary (pool of 3) .a 1732 to 2133 20 to 421   AAA   402/421
(95 %)
6 diff
(98.6 %id)
AW974044   .a 1842 to 2135 294 to 1     Submitted on the opposite strand 294/429
(68 %)
1 diff
(99.8 %id)
BX118113 breast .a 1845 to 2136 1 to 292   AAA   292/292
(100 %)
1 diff
(99.7 %id)
AA557325 breast .a 1875 to 2136 263 to 2       262/263
(99 %)
0 diff
(100 %id)
W56203 Pancreas, pancreatic islet .a 1901 to 2132 1 to 232   fully sequenced,   232/232
(100 %)
4 diff
(98.3 %id)
AI003172   .a 1912 to 2135 240 to 17   AAA   224/224
(100 %)
0 diff
(100 %id)
W60516 Pancreas, pancreatic islet .a 1926 to 2135 210 to 1   fully sequenced,   210/210
(100 %)
0 diff
(100 %id)
AK308377 ovary, tumor tissue .b 1 to 1075 1 to 1076   tiling clone,   1076/1076
(100 %)
1 diff
(100.0 %id)
DB192001 ovary, tumor tissue .b 2 to 555 2 to 556   capped   555/555
(100 %)
1 diff
(99.9 %id)
DA948288 Spleen .c 1 to 573 9 to 583   tiling clone, capped   582/582
(100 %)
3 diff
(99.5 %id)
DB226437 trachea .c 4 to 555 2 to 553   tiling clone, capped   552/552
(100 %)
0 diff
(100 %id)
BI464576 testis .c 5 to 759 1 to 755       755/755
(100 %)
9 diff
(98.9 %id)
DN917526   .c 35 to 582 1 to 545       545/545
(100 %)
7 diff
(98.8 %id)
AK023587 placenta .c 366 to 2260 1 to 1895 exact tiling clone, available from FLJ,   1895/1895
(100 %)
0 diff
(100 %id)
AU137208 placenta .c 367 to 1053 2 to 696   capped   695/712
(97 %)
15 diff
(97.9 %id)
AU157075 placenta .c 1669 to 2260 589 to 1       589/591
(99 %)
25 diff
(95.8 %id)
AK296018 subthalamic nucleus .d 1 to 875 1 to 875 exact tiling clone,   875/875
(100 %)
0 diff
(100 %id)
DC338653 subthalamic nucleus .d 1 to 555 1 to 555 exact     555/555
(100 %)
0 diff
(100 %id)
AA352617   .e 1 to 292 7 to 298 S31A L32W A33L F34S E35K ... tiling clone,   292/298
(97 %)
7 diff
(97.7 %id)
AV754142 pituitary tumor .e 25 to 335 1 to 311   tiling clone, AAA   311/311
(100 %)
1 diff
(99.7 %id)
DB087118 testis .f-u 1 to 564 8 to 573 R14L E15G H16T R17Q E18R ... tiling clone, capped   572/572
(100 %)
2 diff
(99.7 %id)
DB280882 uterus .f-u 14 to 560 2 to 548 exact tiling clone, capped   547/547
(100 %)
0 diff
(100 %id)
AV758320 bone marrow Gene UTP11L, variant not shown       AAA Suspected internal deletion, this clone was ignored    
W69417 heart Gene UTP11L, variant not shown         This clone was ignored    
W69561 heart Gene UTP11L, variant not shown         This clone was ignored    
BF218845 brain, glioblastoma Gene UTP11L, variant not shown         This clone was ignored    
BF572005 melanotic melanoma, high MDR, skin Gene UTP11L, variant not shown         Suspected internal deletion, this clone was ignored    
CB958409 Pooled-Glandular Gene UTP11L, variant not shown         Suspected internal deletion, this clone was ignored    
BQ081876 Ascites, stomach Gene UTP11L, variant not shown         Submitted on the opposite strand, submitted on the opposite strand    
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d, .e, .f-u Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes DC